(Sales figures are not comparable due to change in taxation system to GST from September 2017 quarter)

The top-line grew 10% at Rs 657.59 crore driven by focus on business fundamentals. Both the feminine care and health care business delivered strong growth behind brand fundamentals, strength of product portfolio and improved in store execution.

OPM has inclined by 330 bps to 28.5% due to increase in purchase of stock in trade, employee cost and ASP to adjusted net sales. The operating profit increased by 24% to Rs 187.45 crore.

Other income decreased by 84% to Rs 3.54 crore. Interest cost decreased by 5% to Rs 0.41 crore. Depreciation inclined by 1% to Rs 12.84 crore. PBT has increased by 11% to Rs 177.74 crore.

The tax outgo inclined by 11% to Rs 115.56 crore. The effective tax rate flat at 35%. As a result, the net profit has increased by 11% to Rs 115.56 crore with continued focus on productivity and cost efficiency.

Performance for year ended June 2017

The top-line inclined by 2% to Rs 2320.40 crore despite challenges of liquidity crunch in the second quarter and trade destocking ahead of GST in the fourth quarter. The company responded to these challenges with agility and continued to strengthen brand fundamentals. OPM has inclined by 200 bps to 28.6%. The operating profit increased by 10% to Rs 664.63 crore.

Other income decreased by 12% to Rs 77.30 crore. Interest cost increased by 66% to Rs 10.42 crore. Depreciation inclined by 16% to Rs 59.74 crore. PBT has increased by 6% to Rs 671.77 crore.

The tax outgo inclined by 12% to Rs 239.04 crore. The effective tax rate increased from 33.5% to 35.6%. The net profit has increased by 2% to Rs 432.73 crore.

The promoters hold 70.64% stake in the company

The shares of the company are trading around Rs 8800 at BSE.